API's

Active Pharmaceutical Ingredients - Commercial

Name of the ProductPharmacopeia
Tech Pack
CEP
USDMF
Therapeutic Use
VildagliptinIH
Y
-
-
AntiDiabetic
LevetiracetamIP/USP/Ph-Eur/IH
Y
Y
**
Antiepileptic
MolnupiravirIH
Y
-
-
Antiviral
Rosuvastatin Calcium AmorphousIP/USP/Ph-Eur/IH
Y
*
**
Antilipemic
* – Filing by November 2024     ** – Filing by December 2024

Active Pharmaceutical Ingredients – Under Scale up

Name of the ProductPharmacopeiaCAS No.Therapeutic Use
Bempedoic AcidIH738606-46-7Lowering LDL Cholesterol
Vonoprazan FumarateIH1260141-27-2Potassium-competetive acid blocker
RivaroxabanIH/Ph.Eur366789-02-8Anti-asthmatic
ApixabanIH/USP503612-47-3Anticoagulant
LinagliptinIH668270-12-0AntiDiabetic
DapagliflozinIH461432-26-8AntiDiabetic

Active Pharmaceutical Ingredients - Under Development

Name of the ProductPharmacopeiaCAS No.Therapeutic Use
ImegliminIH775351-65-0Antihyperglycemic
Dabigatran EtexilateIH211915-06-9Blood Thinner
BrivaracetamIH357336-20-0Antiepileptic
 
NOTE: The products covered under valid patents in India or elsewhere, will be supplied solely for the R&D purposes and submission of information required by Regulatory Agencies in India or elsewhere, as per section 107A of the Indian Patents Act, 1970. Buyers will be solely responsible for any liability associated with the infringement of patents in their respective markets.

Copyrights 2019, All Rights Reserved to ruilaboratories.com